Dare Bioscience, Inc. (DARE) income statement
DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.41−0.04 (-9.87%)
Close on Nov 20, 2026Market cap $6.23MP/E –Yield –
Dare Bioscience, Inc. financial ratios
See a number that looks wrong?